Fibroadipose tissue, a blend of fibrous connective tissue and fat cells, is a normal and even essential component of the human body in many locations. Your heel pads, bone marrow, the tissue surrounding your heart, and the cushioning layers beneath your skin all contain fibroadipose tissue that serves specific mechanical or metabolic purposes. Where the finding becomes concerning is when fibroadipose tissue shows up in places it does not belong, particularly when it replaces functional tissue like muscle fibers or organ cells. Whether a pathology report or imaging study mentioning fibroadipose tissue should worry you depends almost entirely on where it was found and what it appears to be replacing.
Places Where Fibroadipose Tissue Is Entirely Normal
Several body structures depend on fibroadipose tissue to function properly. The plantar heel pad is one of the best-studied examples. This specialized fibroadipose cushion absorbs impact energy every time your heel strikes the ground. Research on barefoot walking shows that the heel pad dissipates about one joule of energy with each step and deforms by roughly ten millimeters under load, operating remarkably close to the threshold at which the tissue would start to cause pain.1Medicine and Science in Sports and Exercise. Force-Deformation Properties of the Human Heel Pad during Barefoot Walking Without this fibroadipose layer, simply walking would be painful.
Subcutaneous fat, the layer of tissue just beneath your skin, is another region where fibrous and adipose components normally coexist. The connective tissue framework within subcutaneous fat forms collagen and elastin networks around individual fat cells, with larger bundles of fibers providing structural support. This architecture gives the tissue its ability to stretch and spring back after being compressed, which is why the fat under your skin does not permanently deform every time you sit down or lean against something.2PubMed. The mechanical properties of human adipose tissues and their relationships to the structure and composition of the extracellular matrix
Epicardial adipose tissue, the fat layer that sits directly on the surface of the heart, is another normal fibroadipose depot. This tissue acts as a metabolic go-between for the heart, secreting signaling molecules that influence how the heart muscle functions. In a healthy state, epicardial fat provides cushioning, supplies fatty acids for energy, and helps regulate local inflammation. The balance between its helpful and harmful effects is delicate, though, and shifts in certain disease states toward promoting cardiovascular problems.3PubMed. Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease
Bone Marrow and the Normal Shift Toward Fat
One of the most common places people encounter the term fibroadipose tissue is in the context of bone marrow. If you have ever had a bone marrow biopsy or even certain imaging studies, you may have seen a note about “fatty marrow” or fibroadipose change. In many cases, this is nothing more than the natural aging process at work.
Starting shortly after birth, the blood-forming red marrow in your bones begins a gradual, lifelong conversion to yellow marrow, which is essentially adipose tissue with a fibrous scaffolding. This process moves from the tips of your limb bones inward, so that by adulthood, most of the marrow in your arms and legs has already converted to fat.4PubMed. Conversion of red bone marrow into yellow – Cause and mechanisms Red marrow persists mainly in the spine, pelvis, ribs, and skull. Imaging studies in healthy older adults routinely show fatty marrow in long bones, and this is expected rather than pathological.
The process can reverse under certain conditions. When the body needs more blood cells, such as during severe anemia or after significant blood loss, yellow marrow can reconvert back to red, blood-producing marrow.5PubMed Central. Bone marrow reconversion – imaging of physiological changes in bone marrow On imaging, this reconversion can look unusual to someone unfamiliar with it, occasionally prompting unnecessary concern. The key point is that fibroadipose bone marrow in the limbs of an adult is typically normal, and even reconversion is a physiological response rather than a sign of disease.
When Fibroadipose Replacement in Muscle Points to Disease
Finding fibroadipose tissue where healthy muscle fibers should be is a different story. In skeletal muscle biopsies, the replacement of muscle by fat and fibrous tissue is a hallmark of several neuromuscular diseases. It shows up prominently in muscular dystrophies, inflammatory conditions affecting the muscles, and chronic motor neuron diseases. The pattern is considered nonspecific in the sense that many different diseases can produce it, but it consistently reflects one thing: the muscle is being lost and replaced by tissue that cannot contract.6PubMed. Fibrous-adipose replacement in skeletal muscle biopsy
Duchenne muscular dystrophy is one of the most severe examples. In this condition, the absence of a structural protein called dystrophin causes muscle fibers to break down progressively. As fibers die, fibrotic tissue fills in the gaps, which blocks regeneration and makes treatment harder.7Neuromuscular Disorders. Duchenne muscular dystrophy fibro-adipogenic progenitors impair muscle function of co-cultured healthy myotubes in a functional 3D model The calves of boys with Duchenne muscular dystrophy often look enlarged rather than wasted, because the fatty and fibrous replacement tissue puffs up the muscle compartment even as functional muscle tissue disappears. Clinicians call this pseudohypertrophy.
What makes fibroadipose replacement in muscle particularly concerning is that it tends to be irreversible. Once a critical mass of muscle has been replaced, the tissue cannot regenerate back to normal. This is one reason early detection of neuromuscular diseases matters so much: treatment can sometimes slow the rate of fibroadipose replacement, even if it cannot undo what has already occurred.
The Heart and Fibrofatty Infiltration
In the heart, finding fibroadipose tissue carries specific diagnostic weight, but interpretation is not straightforward. A certain amount of fat within and around the heart is normal, particularly in the epicardial layer. The question is whether fat and fibrous tissue are replacing functioning heart muscle cells, and if so, whether the pattern fits a recognized disease.
Arrhythmogenic right ventricular cardiomyopathy, or ARVC, is the condition most associated with fibrofatty replacement in the heart. ARVC is typically inherited and involves progressive replacement of right ventricular heart muscle with fibroadipose tissue, sometimes extending to the left ventricle as well.8Manual of Cardiovascular Medicine. Arrhythmogenic Right Ventricular Cardiomyopathy The replaced tissue cannot conduct electrical signals properly, which predisposes the person to dangerous heart rhythm disturbances. ARVC is one of the recognized causes of sudden cardiac death in young athletes.
However, researchers have drawn an important distinction between ARVC and simple fat infiltration of the heart. A landmark study examining autopsy specimens found that ARVC involves not just fat accumulation but also myocardial thinning, myocyte loss, and often signs of inflammation. The researchers concluded that fat infiltration alone is probably a different process and should not be automatically equated with ARVC.9PubMed. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? In clinical practice, cardiac MRI is used to look for the constellation of findings that point toward ARVC, including enlargement of the right ventricle, wall motion abnormalities, and fibrosis, not just the presence of fat.10PubMed. Cardiac MRI in arrhythmogenic right ventricular cardiomyopathy
The practical takeaway here is that a mention of fat or fibroadipose tissue near the heart on an imaging report does not automatically mean you have ARVC. The diagnosis requires a combination of structural, electrical, and sometimes genetic findings. Isolated fat near the heart, particularly in older or heavier individuals, is often an incidental observation.
Fibro-Adipose Vascular Anomaly
Fibro-adipose vascular anomaly, usually abbreviated FAVA, is a relatively recently described condition in which fibroadipose tissue forms a mass within a muscle, intertwined with abnormal blood vessels. FAVA typically appears in children and young adults and tends to cause chronic, often severe pain, which distinguishes it from many other vascular malformations that are painless.11PubMed Central. Case Report of Fibro-Adipose Vascular Anomaly (FAVA) with Activating Somatic PIK3CA Mutation The lesions are benign, meaning they are not cancerous, but they can significantly affect quality of life.
On imaging, FAVA lesions appear as oval-shaped masses with blurred borders, averaging around ten centimeters in their longest dimension, though size varies considerably. MRI is the preferred imaging method and shows a mixed signal reflecting the combination of fibrous, fatty, and vascular components within the mass. A feature called a “fascial tail,” where the lesion extends along the surrounding fascia, has been observed on both ultrasound and MRI in multiple cases.12PubMed. Fibro-Adipose Vascular Anomaly: Characteristic Imaging Features on Sonography and Magnetic Resonance Imaging MRI’s ability to show fat suppression patterns and post-contrast enhancement helps clinicians distinguish FAVA from lipomatous tumors and ordinary venous malformations.13Case Reports in Clinical Radiology. Uncommon, unrelenting, and under recognized – This is fibro-adipose vascular anomaly
At the genetic level, FAVA has been linked to somatic mutations in the PIK3CA gene, meaning the mutations arise in the affected tissue rather than being inherited from a parent. Histological examination reveals venous and lymphatic malformations alongside fibrofatty tissue, regardless of whether the PIK3CA mutation is present in any given case.14PubMed Central. PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA) FAVA remains underrecognized, and patients sometimes go years with unexplained limb pain before the correct diagnosis is reached.
Fibroadipose Changes in the Gut and Pancreas
Crohn’s disease provides one of the most distinctive examples of fibroadipose tissue forming in response to disease. During active Crohn’s inflammation, the mesenteric fat, the fatty tissue that anchors and supports the intestines, undergoes a dramatic transformation. It thickens and sends finger-like projections around the inflamed bowel segments, a phenomenon called “creeping fat.”15PubMed Central. Creeping Fat in Crohn’s Disease-Surgical, Histological, and Radiological Approaches Surgeons encounter this during operations and radiologists can identify it on cross-sectional imaging. Whether creeping fat is primarily protective, acting as a barrier against bacterial invasion from the leaky gut wall, or whether it drives further disease progression, remains an open question. The phenomenon was first described in 1932, but its exact role in the disease is still debated.16PubMed. Creeping Fat in the Pathogenesis of Crohn’s Disease: An Orchestrator or a Silent Bystander?
In the pancreas, fat replacement of normal tissue, called pancreatic lipomatosis, is another context where fibroadipose change may or may not be alarming. The condition is associated with a wide range of factors, including diabetes, obesity, aging, chronic pancreatitis, cystic fibrosis, steroid use, and even blockages in the pancreatic duct from stones or tumors. When pancreatic cells die from any of these causes, the lost tissue is often replaced by fat. Most cases are discovered incidentally on imaging and cause no symptoms at all. Only in rare, extreme cases does the fat replacement become extensive enough to impair the pancreas’s ability to produce digestive enzymes.17PubMed Central. Pancreatic Lipomatosis: An Extensive Pictorial Review The mechanisms driving the fat deposition appear to include inflammatory signals that promote fat accumulation in non-fat tissues, reduced blood supply causing cell death, and in some cases, toxic damage from excess iron in the pancreas.18Journal of the Pancreas. Pancreatic Lipomatosis in a Patient with Pancytopenia and Hypoplastic Bone Marrow
Fibroadipose Tissue Around Nerves
An uncommon but well-documented context for fibroadipose tissue is within and around peripheral nerves. Fibrolipomatous hamartoma is a benign condition where fat cells and fibrous tissue proliferate within a nerve, most often the median nerve in the wrist. The enlarged nerve bundles become interspersed with mature fat cells and fibrous growth, which can compress the nerve and cause symptoms identical to carpal tunnel syndrome.19PubMed Central. Fibrolipomatous hamartoma of the median nerve: A cause of acute bilateral carpal tunnel syndrome in a three-year-old child: A case report and comprehensive literature review This condition is benign but can appear in children, making it an important consideration when carpal tunnel symptoms show up in an unexpectedly young patient.
Fibroadipose Tissue in Reconstructive and Regenerative Medicine
Because fibroadipose tissue is a normal structural component in so many body locations, researchers have been working to harness it for surgical reconstruction and tissue engineering. One active area of research involves decellularizing human adipose tissue, stripping away the living cells and leaving behind the extracellular scaffold of collagen and other structural proteins. This scaffold retains the three-dimensional architecture and growth factors of the original tissue, making it a potential biomaterial for reconstructive plastic surgery, orthopedic repairs, and dental and craniofacial procedures.20Biomaterials and Biosystems. Developing a clinical grade human adipose decellularized biomaterial
A more complex approach involves decellularizing entire tissue flaps that include skin, fat, and intact blood vessel networks. Researchers have developed protocols that preserve the vascular plumbing and nerve pathways within a skin-and-fat flap, then repopulate the scaffold with stem cells and endothelial cells that can form new blood vessels. Early laboratory work has shown that these repopulated flaps support cell integration and the formation of vessel-like structures, pointing toward a future where surgeons could use off-the-shelf tissue flaps rather than harvesting them from a patient’s own body.21PubMed Central. Decellularized skin/adipose tissue flap matrix for engineering vascularized composite soft tissue flaps
Fat grafting, the more established clinical practice of transplanting a patient’s own fat to fill defects or add volume, also depends on the fibroadipose properties of the transplanted tissue. The main challenge with fat grafting is keeping the transferred cells alive. Mature fat cells can tolerate about 24 hours without adequate oxygen at normal body temperature before they start dying. Because grafted fat is placed into an environment with no immediate blood supply, only the cells close enough to the surrounding tissue to receive oxygen by diffusion tend to survive. This is why surgeons inject fat in tiny parcels rather than large clumps, maximizing the surface area in contact with the recipient tissue.22PubMed Central. Special Topic Review: Proposed Methods to Improve the Survival of Adipose Tissue in Autologous Fat Grafting The fibrous component of the transplanted tissue plays a role too, providing a scaffold that helps maintain the graft’s shape while new blood vessels grow into it.
How Context Shapes the Clinical Meaning
If your imaging report or biopsy result mentions fibroadipose tissue, the single most important variable is location. Fat within the bone marrow of your femur at age 50 is unremarkable. Fat replacing muscle fibers on a thigh biopsy in a child with progressive weakness is a red flag. Fat next to the heart could be normal epicardial padding or could be part of an ARVC pattern, depending on what other structural and electrical findings accompany it.
A second variable is what the fibroadipose tissue appears to be replacing. In locations where fat is a native component, like subcutaneous tissue or heel pads, its presence is expected and healthy. When fat and fibrous tissue are filling in for something that should be there, whether that is muscle cells, pancreatic cells, or heart muscle, the underlying question is always what killed the original tissue and whether the process is ongoing. A third consideration is quantity: mild fatty infiltration of the pancreas is almost universal with aging, while extensive replacement that obliterates most of the organ’s architecture is rare and clinically meaningful.
Radiologists and pathologists evaluate fibroadipose tissue against these contextual factors every day. If a report mentions the finding without raising further concerns, it often reflects one of the body’s normal structural arrangements or a mild, incidental change. When additional workup is recommended, it typically means the location, extent, or pattern of the fibroadipose tissue fits a recognizable disease profile that warrants closer attention.